Clinical trials
Suspended Neoplasm Metastasis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Enzon Pharmaceuticals, Inc. | 2 |
| AstraZeneca | 1 |
| Baptist Health South Florida | 1 |
| City of Hope Medical Center | 1 |
| David Wald | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Cancer Institute (NCI) | 1 |
| NextPoint Therapeutics, Inc. | 1 |
| Rutgers, The State University of New Jersey | 1 |
| Synta Pharmaceuticals Corp. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 13 |
| Adenocarcinoma | 2 |
| Carcinoma, Renal Cell | 2 |
| Colorectal Neoplasms | 2 |
| Hematologic Neoplasms | 2 |
| Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Bulbo-Spinal Atrophy, X-Linked | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.